Inhibition of STING reduced this pro-inflammatory polarization, suggesting that targeting the mtDNA-STING axis could shift microglial polarization toward an anti-inflammatory phenotype, offering potential therapeutic benefits for ischemic stroke and TBI (Kong et al., 2022). Here, STING1 is linked to ischemic stroke.